Tipranavir
Tipranavir is a protease inhibitor effective against multi-PI-resistant HIV-1, inhibiting both viral protease activity and dimerization. It also demonstrates inhibitory activity against SARS-CoV-2 3CLpro, making it a useful research tool for studying antiviral mechanisms in vitro.
Product Specifications
CAS Number
174484-41-4
Product Name Alternative
HIVProtease, HIV-1 protease, HIV Protease, PNU140690, PNU-140690, PNU 140690, Tipranavir, SARS CoV-1 3CLpro, SARSCoV
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.66% (May vary between batches)
Solubility
DMSO:260 mg/mL (431.42 mM) ; Ethanol:45 mg/mL (74.67 mM)
Smiles
CCC[C@@]1 (CCc2ccccc2) CC (O) =C ([C@H] (CC) c2cccc (NS (=O) (=O) c3ccc (cn3) C (F) (F) F) c2) C (=O) O1
Molecular Formula
C31H33F3N2O5S
Molecular Weight
602.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
MAGic Clamp magnetic clamp 3000mL Erlenmeyer (max. 4)
LOX1 (Oxidized Low-density Lipoprotein Receptor 1, Ox-LDL Receptor 1, C-type Lectin Domain Family 8 Member A, Lectin-like Oxidized LDL Receptor 1, LOX-1, Lectin-like oxLDL Receptor 1, hLOX-1, Lectin-type Oxidized LDL Receptor 1, OLR1, CLEC8A) (PE)
LOX1 (Oxidized Low-density Lipoprotein Receptor 1, Ox-LDL Receptor 1, C-type Lectin Domain Family 8 Member A, Lectin-like Oxidized LDL Receptor 1, LOX-1, Lectin-like oxLDL Receptor 1, hLOX-1, Lectin-type Oxidized LDL Receptor 1, OLR1, CLEC8A) (PE)
Human NDUFS5 AssayLite™ Antibody (FITC Conjugate)